Clinical Channel Icon 

As the biopharma industry faces the challenge of increasing costs and high probability of clinical failures, more emphasis is placed on strategies to de-risk and innovate drug development. The wide availability of genomic technologies acts as the prime driver of innovation in the clinical development field. The Clinical Channel will explore strategies, tools and technologies to improve translation and clinical development.

Epigenomics in Disease

Genomic Technologies for Patient Stratification

Translational to Clinical R&D

Clinical Sequencing

Technology-Driven Oncology Clinical Development


You may also be interested in:


New Frontiers in Gene Editing- NEW

Circulating Cell-Free DNA

Genomics in Medicine

Genomics & Sequencing Data Integration Analysis and Visualization

Clinical Cancer Immunotherapy - NEW

Short Courses:

Translating CTCs to Clinical Use

Latest Advances in Molecular Pathology

Sequencing 101

PCR Part I: Primer Design for PCR Experiments

Knowing Your NGS Analysis Upstream

Regulatory Compliance in Molecular Diagnostics

Isolation and Characterization of Cancer Stem Cells

Using Preclinical Models in Oncology

Best Practices in Personalized and Translational Medicine

NGS for Infectious Disease Diagnostics


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 


2015 MMTC Final Agenda 

Premier Sponsors:


Jackson Laboratory - small logo 

Leica Biosystems 



Silicon Biosystems 



Thomson Reuters-Large 

Local Partners:




City of SSF